Novacap International
LEI 549300BPEJ5VNR7YT002
Upgrade to Premium features
Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market
Get access-
Full access to the largest bond database
Bond parameters,
prospectuses -
Seamless
Data exportAnalyze the data in the most efficient way
-
Bond pricing
Current & historical quotes from 400+ stock exchanges & OTC market
-
Smart risk assessment
Credit ratings, financial reports
Trading Schedule Issuer map
Quotes
- «
- 1
- ...
- {{ quotes.page - 2 }}
- {{ quotes.page - 1 }}
- {{ quotes.page }}
- {{ quotes.page + 1 }}
- {{ quotes.page + 2 }}
- ...
- {{ quotesLastPage }}
- »
Profile
|
Novacap is a leading manufacturer and distributor of essential chemicals for use in everyday products. We have a very wide range of products among which salicylic acid and aspirin for which we are the worldwide leader, paracetamol and para-aminophenol, soda ash and sodium bicarbonate, phenol and oxygenated solvents, hydrochloric acid and derivatives which are used in growing end-markets such as pharmaceutical & healthcare, food & feed, cosmetics & fragrances, home care and environment. Construction and automotive markets are historical markets for which we are also a reference partner.
We are a supplier to more than 650 customers across more than 80 countries, including worldwide industry leaders with which we have privileged and long-standing relationships, like with our own suppliers.
With 11 facilities and 1245 people worldwide of which 51% in Asia, the Group benefits from a global commercial network and a global regulatory infrastructure.
|
General information
-
Organization nameNovacap International SAS
-
Organization statusLiquidated
-
Address21 Chemin de la Sauvegarde CS 33167 Ecully, France, 69134
-
Site









